Recent Finacing
Recent Raise
CND Life Sciences develops and commercializes the Syn-One Test, a skin-biopsy diagnostic that visualizes and quantifies misfolded alpha-synuclein in cutaneous nerve fibers and operates a CLIA/CAP-accredited laboratory.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at CND Life Sciences.
